Drug Trial Radar · NCT06866691
Seizure Prevention in Traumatic Brain Injury With Levetiracetam and Lacosamide
Last checked: Nov 20, 2026Latest source record: Apr 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
600
Planned (sponsor's estimate)
Start
Apr 18, 2025
Primary completion
Apr 2027
Study completion Apr 2027
Sponsor
- Lead sponsor
- Wake Forest University Health SciencesAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Mar 10, 2025
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the incidence of early post-traumatic seizures. The study will also assess the benefit of lacosamide compared to levetiracetam in regards to agitation and behavioral adverse effects in patients with traumatic brain injury requiring seizure prophylaxis.
Conditions
- Traumatic Brain Injury
Interventions
levetiracetamDrug
levetiracetam 1000 mg intravenously or by mouth twice daily for a total of 7 days
lacosamideDrug
lacosamide 200 mg intravenously or by mouth twice daily for a total of 7 days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of Early Post-traumatic SeizureTime frame: Up to day 7 post injury
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Wake Forest University Health Sciences
Winston-Salem, North Carolina · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.